Independence Is Not a Strategy for Health Systems

http://www.healthleadersmedia.com/leadership/independence-not-strategy-health-systems?spMailingID=11725844&spUserID=MTY3ODg4NTg1MzQ4S0&spJobID=1221639238&spReportId=MTIyMTYzOTIzOAS2#

Image result for john gribbin centrastate

There are ways to keep going it alone in the face of massive consolidation, says one health system’s CEO. It’s not a strategy, but a means to end, he says.

Afraid your hospital or health system can’t compete because you lack size and scale?

A merger might help, but it’s not the only possible answer to your problems. Freehold, NJ-based CentraState Healthcare System’s top leader is certain it’s not the best solution for his organization.

Consolidation continues to upend the acute and post-acute healthcare industry. In fact, in a recent HealthLeaders Media survey, some 87% of respondents said that their organization is exploring potential deals, completing deals already under way, or both.

But CentraState isn’t among them, says John Gribbin, its president and CEO.

On a continuum basis, CentraState is already diversified. That’s one of the potential selling points of an M&A deal.

Anchored by the 248-bed CentraState Medical Center in Freehold, NJ, the 2,300-employee organization also contains three senior care facilities—one assisted living, one skilled-nursing facility, and a continuing care retirement community.

It can be argued that CentraState may not possess the scale to compete with multifacility, multistate large health systems that can take advantage of a hub-and-spoke strategy for referrals. Nor may it be able to afford expensive interconnected IT systems.

But there ways other than mergers to achieve scale and collaboration, says Gribbin.

Means to an End

Gribbin insists that he and CentraState’s board, which supports and encourages independence, are not dogmatic about it.

“Independence is not a strategy,” he says. “It’s a means to an end. The moment that ceases to be worthwhile is the moment we’ll consider another way to achieve our mission.”

Change is part of that strategy, he says, adding that healthcare in 2017 needs to be far more collaborative, not only with patients and family, but with other healthcare organizations. That’s a big difference from previous generations.

“Our real strategy is scale and relevancy,” he says.

And there are ways to create scale short of taking on all the legacy costs and “baggage,” as Gribbin calls it, inherent in any merger.

“There’s a lot of costs involved in merging… and while mergers work in some instances, they don’t work in all, and in many communities, they are increasing costs to the consumer,” he says.

In addition to the commonly stated goals of improving the community’s health and wellness, patient costs are extremely important in fulfilling CentraState’s mission, Gribbin argues.

Many mergers involve replacing hospitals and adding patient towers and high-cost equipment. That adds to their cost structure means they have to extract higher pricing, says Gribben.

“That’s the vicious circle you find yourself in. I prefer to create scale in a different manner.”

Focus on the Mission

Gribbin, who has led CentraState for 17 years, prefers to solve that challenge in part through a strong network of physicians unburdened by excessive administrative overhead.

He says the health system has to increasingly take on value-based contracting and financial risk. To be successful under such value-based reimbursement, partnerships with physicians are increasingly important, as is a redefinition of the relationship with the patient.

“We used to look at our relationship with the patient as a typical hospital stay,” says Gribbin. “What we’re preaching now is that hospital stay is a temporary interruption in our relationship. What happens before or after defines the relationship’s success.”

With its physician alliance and clinically integrated network in place, CentraState, unlike many hospitals, has been able to avoid, in large part, expensive physician practice acquisitions that can be a financial challenge.

“I’ve done it in the past, and may do it again, but we’ve tried to avoid it,” he says. Instead, contracts define the relationships and incentives.

As an example of those relationships, CentraState partners with a major patient-centered medical home primary care practice on four performance and three utilization measures.

As a result of the shared savings generated in the first year, which came largely from hospital-based savings, the physicians in that group referred 59% of their patients to CentraState.

This year they’ve referred 71% of their patients to CentraState because of its low costs, which help drive financial reward for both parties under the contract.

“On one hand, we’re keeping people appropriately out of acute care, but on the other hand, they’re sending [more] people here. So we’re experiencing higher but more appropriate volume. In this scenario, everyone wins,” Gribbin says.

A New Deal with Physicians

In order to avoid the need to acquire physician practices, Gribbin says it helps to have a suite of services to offer them as a starting point.

“Most don’t want to sell their practice, but they feel like they have to, he says. “If you give them the opportunity to stay independent, they’ll take it.”

Helping them with access to better revenue cycle management, malpractice insurance, and risk management, and helping them create the ability to enter into risk-based contracts is another big help with defining a new relationship based on shared goals with physicians that ultimately benefit the patient, he says.

Physicians can establish a relationship with CentraState through its independent practice association, or a physician hospital association, and avoid surrendering their autonomy, he says.

“The physicians got paid better, the payer saved money even including the bonus, the hospital won because it’s high value care, and the patient’s winning too,” he says. “It’s a microcosm of what we’re trying to accomplish.”

As a small organization, both Gribbin and the board worry about being frozen out of narrow networks. Much of the energy they’ve expended in being a low-cost organization is wasted, he says, if they can’t get the big payers to include them in contracting.

“As long as the market isn’t rigged against us, we’re OK, because we’re a high-value organization.”

Palomar Health sticks with medical group it created despite $82 million loss

http://www.sandiegouniontribune.com/news/health/sd-me-palomar-arch-20170709-story.html?utm_campaign=CHL%3A%20Daily%20Edition&utm_source=hs_email&utm_medium=email&utm_content=54042734&_hsenc=p2ANqtz-9hDUhREKmtOodn7xHPbQ-Lboo-SRrHug0TOWa2Vf2-aO1_7BI–L59apzQMQ8dw-H7GfgiCl_O-H5VTZM6WaoYrAG2rw&_hsmi=54042734

Image result for Palomar Health sticks with medical group it created despite $82 million loss

Palomar Health in Escondido will continue to support the medical group it helped to created seven years ago despite mounting losses that have reached $82 million.

While it might seem intuitive for the North County hospital operator to pull the plug on a relationship that has run in the red for seven years now, experts said market forces that require doctors and hospitals to work together more closely are keeping partnerships like this one intact — even if they bleed cash.

At its meeting Monday, Palomar’s elected governing board is set to forgive a line of credit that was extended to Arch Health Partners Medical Group for $76 million in principal and $6 million in interest. In exchange, the public health district and the medical group would agree to share responsibility for Palomar’s present and future debts, which currently exceed $500 million, according to the district’s most recent financial statements.

Big players such as Kaiser Permanente, Scripps Health and Sharp HealthCare have been creating special doctor groups for decades as a way of feeding patients to the hospitals they operate. California law forbids them from requiring physicians to send their patients to any specific location for care, but these arrangements nonetheless, make it more likely that patients seen in an affiliated medical office will end up in a facility of the same name when they need hospitalization.

The Affordable Care Act only accelerated this trend when it started penalizing hospitals for patients who are readmitted shortly after being sent home.

New payment programs established by the government and private insurers have also started offering better reimbursement to organizations that can deliver high-quality care at a lower cost. Being able to pull off that feat means now is not the time to walk away from a partner like Arch, even though that medical group estimates a $14 million operating loss this year and an $11 million loss for next year, said Della Shaw, Palomar’s executive vice president of strategy.

“The reality today is that it’s nearly impossible for a system to operate without an aligned physician group,” Shaw said.

Though it has not operated in the black and currently cannot say when — or if — it will be able to do so in the future, Shaw said Arch has been crucial in helping Palomar turn around a financial mess that had it operating at a $22.2 million deficit in 2013, one year after opening the $956 million Palomar Medical Center in Escondido.

Today, according to Palomar chief financial officer Diane Hansen, the health district is expected to post a $20 million profit on its operations and will have increased its savings for four years in a row.

Palomar’s willingness to sink cash into Arch year after year has not been without opposition.

Graybill Medical Group, one of the largest independent health operators in North County and an entity that has supported Palomar for decades, has regularly objected to the ever-growing subsidy for Arch. Its doctors have occasionally raised questions about Arch’s management decisions and financial strategies at public meetings of Palomar’s elected governing board. Graybill has even successfully backed slates of candidates for the board in the past two elections.

The group did not comment Thursday on Palomar’s impending decision to wipe out the debt that it has questioned for years. However, Alan Smith, a San Diego attorney who has served as Graybill’s public affairs adviser, said the group has generally questioned whether creating Arch, which was built from pre-existing specialty and primary care practices that already existed in inland North County, was truly necessary.

“The fear has been, ‘My gosh, if we don’t subsidize these specialists, they’re going to pick up and leave. We don’t think they were going any place, and we just thought there were better places for Palomar to spend its money,” Smith said.

This is not suggesting that Graybill lacks respect for Arch’s doctors, Smith added.

“We love these guys as physicians. The doctors themselves get along famously. They send patients back and forth all the time. It’s just the business model that Palomar created that’s the point of contention,” Smith said.

It does seem that Arch has been able to deliver quality care. Medicare rates the group 4.5 out of five stars from the Centers for Medicare and Medicaid Services, and Arch has twice won the Integrated Healthcare Association’s “Excellence in Healthcare” award.

As to the “why bother?” question that Graybill raises, Deanna Kyrimis, Arch’s chief executive, said in an email that bringing together previously separate groups of doctors under one organizing structure has allowed creation of services that are hard to do on an ad-hoc basis. Sharing electronic infrastructure, for example, is a very important activity that the federal government is increasingly requiring in its payment structures for Medicare.

Shaw, the Palomar strategy executive, added that while private doctor groups — Graybill chief among them — have been great allies, creating Arch has allowed the health care district to open offices in areas such as Ramona, Rancho Peñasquitos and Rancho Bernardo, where there is either fierce competition with larger health operators or where demographics are more financially challenging. Subsidizing Arch has allowed Palomar to request that certain services, such as mental health, be bolstered even though doing so would not make financial sense to an independent group, she added.

“There is no margin in that service. However, Arch Health Partners was able to fill that gap that needed filling in the safety net,” Shaw said. “That’s an example of where I would say the subsidy we have provided has been effective for the public.”

But it is also clear that Arch’s business model has required some refinement.

Kyrimis, who was hired in late 2014 during a major management shake-up, said the group previously provided an average subsidy of $415,000 per doctor in 2015. The number has been reduced to $261,000 this year and is expected to fall further to $192,000 in 2018.

The executive said she has been able to bring costs down by reducing employee benefits and salaries after a financial review in 2015 showed they were above industry averages.

“Fortunately, the staff overages were in administrative areas — furthest away from the patient, if you will,” Kyrimis said. “We have reduced our administrative management and administrative support staff to the appropriate level.”

The cost-cutting process has not been without protest. A well-known cardiologist spoke up at a recent board meeting about being forced out of the group for no good reason, and those remarks were immediately followed by a rebuttal statement from Arch’s lawyer.

It is hard to say exactly how the Arch experience compares to other, often much larger relationships between medical groups and hospitals. Most of those tie-ups — such as the ones for Sharp HealthCare, Scripps Health and Kaiser Permanente — involve privately run nonprofits and thus do not have to report their year-end results publicly.

Penny Stroud, founder of Cattaneo & Stroud, a health care consultancy that collects and publishes a California medical group inventory list for the California Healthcare Foundation, said it is very difficult to create a new medical group these days, especially in San Diego County.

“The investments are so high for everything from electronic medical records to recruiting and retaining physicians. Especially in primary care, it’s a high-overhead, low-margin business, and the San Diego marked is so consolidated among a small handful of very large players that it’s a very challenging environment for a smaller group,” Stroud said.

She added that it is not uncommon for hospital operators to regularly subsidize the medical groups they affiliate with, though that cash flow is generally not shared publicly.

Typically, she said, medical groups that operate in areas with high concentrations of Medicare and Medicaid patients generally tend to need more support than those in areas with lots of people who are privately insured. In addition, offering ancillary services — from X-ray suites to private labs — can make the difference between those that are profitable and those that aren’t.

Setting up multi-specialty groups, especially cobbling them together from existing practices as Arch has done, is always expensive. But an $82 million loss over seven years? Isn’t that a lot of cash?

“It would certainly cost as much for Palomar to develop its own foundation-model medical group from scratch anywhere where you have a highly competitive market like you have in San Diego,” Stroud said.

As Healthcare Changes, So Must its CEOs, CFOs, COOs…

http://www.healthleadersmedia.com/leadership/healthcare-changes-so-must-its-ceos-cfos-coos%E2%80%A6?spMailingID=11163372&spUserID=MTY3ODg4NTg1MzQ4S0&spJobID=1180078976&spReportId=MTE4MDA3ODk3NgS2

To keep up with big changes in how healthcare is administered, financed, and organized, top leaders are finding a need for new talents and organizational structures.

To keep up with big changes in how healthcare is administered, financed, and organized, top leaders are finding a need for new talents and organizational structures.

Healthcare reform as a term has become so ubiquitous that it is almost indefinable. At first, and broadly, it meant removing the waste in an excessively expensive healthcare system that too often added to the problems of the people whose health it aimed to improve. Then it became legislative and regulatory, in the form of the Patient Protection and Affordable Care Act and its incentives aimed at improving the continuum of care and expanding the pool of those covered by health insurance.

Now, for many in the industry, healthcare reform has matured into a business imperative: the process of ingraining tactics, strategies, and reimbursement changes so that health systems improve quality and efficiency with the parallel goal of weaning us all off a system in which incentives have been so misaligned that neither quality nor efficiency was rewarded.

That leaders finally are able to translate healthcare reform into action is welcome, but to many health systems trying to survive and thrive in a rapidly changing business environment, the old maxim that all healthcare is local is being proved true. Making sense of healthcare reform is up to individual organizations and their unique local circumstances. Fortunately, there are some broad themes and organizational principles that are helpful for all that are trying to make this transition. What works in one place won’t necessarily work in another, but the innovation level is off the charts as healthcare organization leaders reshape what being a leading healthcare organization means as well as what it requires.

Top 10 MACRA Considerations for Providers

http://www.healthleadersmedia.com/physician-leaders/top-10-macra-considerations-providers?spMailingID=11001571&spUserID=MTY3ODg4NTg1MzQ4S0&spJobID=1160968896&spReportId=MTE2MDk2ODg5NgS2

Image result for MACRA

Most physician practices are running a race against time to implement Medicare’s value-based payment system, survey data indicates. They have a lot to think about as they go about it.

As Medicare’s reviled Sustainable Growth Rate (SGR) formula for physician reimbursement fades to extinction, its replacement, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, is posing a new set of challenges.

This week Black Book Research identified 10 of the top MACRA challenges that physician practices are facing. The survey is based on responses from 8,845 physician practices collected from February to April.

1. MIPS compliance technology: Physician practices are seeking technological solutions to help them achieve reporting compliance, with 77% of practices that have at least three clinicians mulling the purchase of Merit-Based Incentive Payment System Compliance Technology Solutions (MIPS) software.

2. Electronic Health Record (EHR) optimization: MACRA appears to be a golden opportunity for the largest EHR vendors. For the top eight EHR companies, 83% of their physician-practice users reported working to upgrade their system for MIPS compliance. At physician practices with smaller EHR vendor partners, however, 72% reported they were not working with their vendor partner to upgrade their system for MIPS compliance.

3. Consultant opportunity: The EHR capabilities required for participation in MIPS or Alternative Payment Models (APMs) represent a business opportunity for EHR consultants. Most (80%) of physician practices report that conducting a technology inventory is key to strategic planning for a value-based payment system.

4. Data wrangling: Taming data to conform with the reporting requirements of MIPS and APMs is daunting for many physician practices. At practices with at least four clinicians, 81% of physicians report being unable to align their data with the new reporting requirements.

5. Paying for procrastination: Physician practices that have not developed an in-house strategy for participating in MIPS or an APM are looking for outsourcing options. Of these practice procrastinators, 80% are planning to find turnkey software or a MACRA-administration partner this year.

6. MACRA-induced physician-practice consolidation: Black Book found that three-quarters of independent physician practices surveyed are considering selling their practice to a health system, hospital, or large group practice because of the regulatory and capital-cost burdens of MACRA.

In an equally dour data point, 68% of independent physicians predicted that MACRA would either burden or bankrupt their practice by 2020.

7. Economic incentives: For the first five years of the Quality Payment Program, there are powerful economic incentives to beat the MIPS performance threshold.

In 2019, MIPS is set to redistribute about $199 million from physicians who perform below the performance threshold to physicians above the threshold, and this redistribution mechanism is set to expand over time.

There also is $500 million in supplemental funding available for each of the first five years of MIPS implementation. To chase these opportunities, 64% of hospital-networked physician organizations reported including incentives in physician-compensation packages to boost MIPS performance.

8. Reputation risk: A majority (54%) of those surveyed did not know that MACRA would result in performance data being reported publicly through Medicare’s Physician Compare website and other rating systems.

9. ACO appeal: Joining an accountable care organization can increase the odds of MIPS success through penalty avoidance and resource utilization bonuses. Small physician practices have taken notice, with 67% considering joining an ACO to increase the likelihood of MIPS success.

10. Cost and quality transparency: Based on its physician-practice survey and other research, Black Book Research expects MACRA to be one of the market factors driving healthcare cost and quality transparency.

One survey noted 52% of large group practices, independent practice associations, ACOs, and integrated delivery networks reported they were preparing to release cost and quality measures for individual physicians by next year.

 

Mayo Clinic Prefers Privately Insured Patients. So What?

http://www.healthleadersmedia.com/leadership/mayo-clinic-prefers-privately-insured-patients-so-what?spMailingID=10772724&spUserID=MTY3ODg4NTg1MzQ4S0&spJobID=1140471104&spReportId=MTE0MDQ3MTEwNAS2#

John Noseworthy, MD

You may have heard that John Noseworthy, MD, the president and CEO of the Mayo Clinic, recently told employees that the Rochester, MN-based health system will give preference to patients with private insurance over those who rely on Medicaid or Medicare.

At this point it’s safe to say he wishes he hadn’t said that.

Predictably, that statement opened up a nasty public relations crisis for which the health system has still not fully recovered, even two weeks later. I asked to speak with Noseworthy, but through a spokesperson, he declined to further address the issue beyond the written statement proffered after the Internet exploded in reaction to his comments.

Physician: Consequences of ACA Repeal ‘Gigantic for Us’

http://www.healthleadersmedia.com/physician-leaders/physician-consequences-aca-repeal-gigantic-us?spMailingID=10400909&spUserID=MTY3ODg4NTg1MzQ4S0&spJobID=1100770334&spReportId=MTEwMDc3MDMzNAS2#

Image result for Physician ACA

Physician organization leaders are trying to plot business strategies for a post-ACA landscape of increased healthcare consumerism, lower reimbursement, and new partnerships.

As Commercial Capitation Sinks, Can California’s Physician Organizations Stay Afloat?

http://www.chcf.org/publications/2016/11/commercial-capitation-sinks

Image result for Boat Staying Afloat

California is seeing the decline of capitation — fixed prepayment for care of a defined population — particularly for commercial health insurance products. This issue brief explores the impact of this trend on the state’s medical groups and independent practice associations (IPAs). The main question at hand is whether California’s delegated model will remain sustainable with lower levels of commercial capitation.

The analysis is based on both quantitative and qualitative data. The medical group and IPA leaders interviewed for this research made a number of observations, including:

  • The near future is uncertain. Declining capitation has not yet had a big impact on their operations, but they suspect it may soon.
  • Change thus far has been slow enough that organizations have been able to adapt.
  • Declining prepayment will not impact clinical decisionmaking.
  • Medicare and Medi-Cal offer more opportunities to accept capitation, but these do not necessarily compensate for the loss of commercial capitation.
  • Leaders are concerned that high deductibles may adversely affect the health of patients.

The research points to the importance of continuing to track changes in the payment environment of California’s capitated, delegated physician organizations. Although the decline in commercial capitation has been slow enough that it has not yet led to significant changes in operations, it may soon do so.

The full issue brief is available as a Document Download.

Click to access PDF%20CommercialCapitationSinks.pdf

 

ICD-10 turns 1: Was it so bad?

http://www.healthcaredive.com/news/icd-10-turns-1-was-it-so-bad/427115/

R51: headache. Gearing up for the switch from ICD-9 to ICD-10 last October, many providers expected nothing but headaches. The new system increased the number of diagnostic codes from around 13,000 to about 68,000, requiring clinicians to sift through highly specified conditions — and some unusual ones, such as W61-62XD: struck by duck.

But after a year of using the ICD-10 — and the impending end of a one-year grace period that ensured providers wouldn’t be denied Medicare Part B claims as long as they used a code from the correct family — most physicians say the implementation process went better than expected.

“The fear that this was really going to impact us financially because of the potential inability to process the new codes really never transpired,” says Michael Munger, a family physician with Saint Luke’s Medical Group in Overland Park, KS, and president-elect of the American Academy of Family Physicians.

In fact, the error rate for claims tracked by the AAFP was the same this year as it was for ICD-9 — 10%. The fact that commercial insurers didn’t have the grace period bodes well for the loss of flexibilities, since doctors should be used to being more specified in their claims.

CMS needs to halt the march to health care gigantism

CMS needs to halt the march to health care gigantism

From a major speech by Sen. Elizabeth Warren to a recent report from the President’s Council of Economic Advisers, there has been a renewed interest by Democrats in monopolies and market consolidation. From tech to airlines, they argue, too many sectors of the economy are being dominated by a few big players.

In American health care, this is not only the case, but has been the default preferred stance. In health care, there is an almost Darwinian belief that the evolution to bigger is better. This is why last year saw 112 hospital mergers (up 18 percent from 2014), and the percentage of physician practices owned by hospitals doubled between 2004 and 2011.
Yet, there is no evidence that consolidation of hospitals and physician practices leads to better clinical outcomes or cost reductions. In fact, recent studies suggest that small, physician-owned practices have a lower average cost per patient, fewer preventable hospital admissions, and lower readmission rates than hospital-owned practices.
That is why it is so unfortunate that, as part of the largest rewriting of doctor payment rules in a generation, the Centers for Medicare and Medicaid Services (CMS) unwittingly has drafted regulations that—as currently proposed—further neglect the power of physician independence and create strong incentives for further consolidation in health care.

The Tangled Hospital-Physician Relationship

http://healthaffairs.org/blog/2016/05/09/the-tangled-hospital-physician-relationship/

Blog_healthcare management